tailieunhanh - Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents – a real-world cross-sectional study from Switzerland (SAKK 95/16)

Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care use on patient-reported pain and bone painrelated quality of life (QoL) is limited. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN